GISAID

From Food & Medicine Encyclopedia

Revision as of 01:50, 18 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

GISAID (Global Initiative on Sharing All Influenza Data) is a global science initiative and primary source that provides open-access to genomic data of influenza viruses and the coronavirus responsible for the COVID-19 pandemic.

History[edit]

GISAID was launched in 2008, in response to the H5N1 avian influenza. It was established as a mechanism to share influenza data, following the reluctance of certain countries to share their data due to concerns about intellectual property rights.

Function[edit]

GISAID promotes the international sharing of all influenza virus sequences, related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses. GISAID does so by overcoming disincentives/hurdles that discourage or prevent sharing of influenza data.

Role in COVID-19 pandemic[edit]

During the COVID-19 pandemic, GISAID has played a crucial role in the global response. It has served as the primary source of genome sequences of SARS-CoV-2, the virus responsible for the disease, with laboratories around the world submitting their sequences to the database.

See also[edit]

References[edit]

<references />

External links[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.